Urologix, Inc. announced revenue guidance for its second quarter of fiscal year 2015 ended on December 31, 2014. For the, second quarter of fiscal year 2015 revenue is expected to be approximately $3.1 million, up approximately 2% sequentially from the first quarter of fiscal year 2015. The second quarter revenue was down approximately 19% compared to the second quarter of the prior fiscal year, which was the last full quarter of operations before the Company restructured its sales and operations in the second half of fiscal year 2014.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -.--% |
2016 | A unknown buyer acquired substantially all of the operating assets of Urologix, Inc. | CI |
2015 | Urologix Conducting A Strategic Review | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 2.13K | |
+7.01% | 217B | |
+11.01% | 190B | |
+19.20% | 143B | |
+30.79% | 111B | |
+1.48% | 64.59B | |
+13.95% | 52.36B | |
-0.16% | 48.45B | |
-6.20% | 38.03B | |
+0.91% | 35.61B |
- Stock Market
- Equities
- ULGX Stock
- News Urologix, Inc.
- Urologix, Inc. Announces Revenue Guidance for Second Quarter Ended on December 31, 2014